Related and Nonrelated Parties [Axis] Related Party [Member] Nonrelated Party [Member] Class of Stock [Axis] Series A Preferred Stock [Member] Series AA Preferred Stock [Member] Series M Preferred Stock [Member] Series NC Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Preferred Stock Series NC [Member] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Measurement Input Type [Axis] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Term [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Measurement Input Expected Volatility [Member] Measurement Input, Expected Dividend Rate [Member] Investment, Name [Axis] Nonconsolidated Investees, Other [Member] Related Party Transaction [Axis] Debt Instrument [Axis] Bostonia [Member] Coventry Enterprises L L C [Member] Legal Entity [Axis] Trillium Pratners LP [Member] Award Date [Axis] Due and Payable On May 3, 2025 [Member] Due and Payable On June 5, 2025 [Member] Due and Payable On October 4, 2025 [Member] Due and Payable On October 15, 2025 [Member] Due and Payable On October 23, 2025 [Member] David Koos [Member] B S T Partners [Member] Zander Therapeutics Inc [Member] Title and Position [Axis] Lender 1 [Member] Lender 2 [Member] Lender 3 [Member] Lender 4 [Member] Lender 5 [Member] Lender Six [Member] Lender Seven [Member] Lender Eight [Member] Lender Nine [Member] May 5, 2017 [Member] March 8, 2016 [Member] April 6, 2016 [Member] December 20, 2017 [Member] October 31, 2016 [Member] September 4, 2024 [Member] Guaranted Interest [Member] October 28, 2024 [Member] Regen Biopharma Inc [Member] Labrys Fund II LP [Member] Derivative Instrument [Axis] Convertible Common Stock [Member] Short-Term Debt, Type [Axis] Convertible Notes Payable [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Information, Former Legal or Registered Name Statement [Table] Statement [Line Items] ASSETS: Current Assets Cash Accounts receivable, related party Prepaid expenses Total Current Assets Investment securities, related party TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Accounts payable Accrued expenses Notes payable Unearned income Derivative liability Convertible notes payable, net of unamortized debt discount Other current liabilities Total Current Liabilities TOTAL LIABILITIES STOCKHOLDERS’ EQUITY (DEFICIT) Common Stock ($.0001 par value) 5,800,000,000 authorized and 351,438,592 and 39,374,704 shares issued and outstanding, respectively Preferred stock, value Additional Paid in capital Other Comprehensive Income Retained Earnings (Deficit) Total Stockholders’ Equity (Deficit) TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY (DEFICIT) Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] Net revenue: Net revenue Operating expenses: Research and Development General and Administrative Consulting and Professional Fees Rent Total operating expenses Profit (Loss) from operations Other income (expense): Interest Expense Interest Expense attributable to Amortization of Discount Derivative Income (Expense) Penalties Financing Fees Total other income (expense), net Net profit (loss) before income taxes Income tax provision Net profit (loss) Net profit attributable to common shareholders Net loss per common share, basic Net loss per common share, diluted Number of weighted average shares - basic Number of weighted average shares - diluted Balance Balance, shares Common Shares issued for Cash Common Shares issued for Cash, shares Common Shares issued for Debt Common Shares issued for Debt, shares Common Shares issued for Interest Common Shares issued for Interest, shares Common Stock issued for services Common Stock issued for services, shares Preferred Shares distributed as dividend in kind Preferred Shares distributed as dividend in kind, shares Net Income ( Loss) Restricted Stock Award , Employee Restricted Stock Award , Employee, shares Restricted Stock Award , Nonemployee Restricted Stock Award , Nonemployee, shares Common Stock paid as dividend Common Stock paid as dividend, shares Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net Income (loss) Adjustments to reconcile net loss to net cash used in operating activities: Changes in derivative liability Increase (Decrease) in Interest expense attributable to amortization of Discount Preferred Stock issued for Compensation Common Stock issued for Compensation Common Stock issued for Expenses (Increase) Decrease in Accounts Receivable (Increase) Decrease in Prepaid Expenses Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Expenses Increase (Decrease) in Penalties Increase ( Decrease) in Unearned Income Net Cash Provided by (Used in) Operating Activities CASH FLOWS FROM FINANCING ACTIVITIES: Increase (Decrease)in Convertible Notes Payable Increase (Decrease)in Notes Payable Increase (Decrease) Other Liabilities Common stock issued for cash Borrowings from notes payable to related parties Net Cash Provided by (Used in) Financing Activities Net Increase (Decrease) in Cash Cash at Beginning of Period Cash at End of Period Supplemental Disclosure of noncash investing and financing activities: Common Shares issued for Convertible Notes Payable Convesion of Notes Payble to Convertible Debt Common Shares issued for interest Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Receivables [Abstract] ACCOUNTS RECEIVABLE Prepaid Expenses PREPAID EXPENSES Payables and Accruals [Abstract] ACCRUED EXPENSES Unearned Income UNEARNED INCOME NOTES PAYABLE NOTES PAYABLE TO RELATED PARTIES Debt Disclosure [Abstract] CONVERTIBLE NOTES PAYABLE Derivative Instruments and Hedging Activities Disclosure [Abstract] DERIVATIVE LIABILITY Equity [Abstract] STOCKHOLDERS’ EQUITY Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Income Tax Disclosure [Abstract] INCOME TAXES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Preparation Principles of Consolidation Use of Estimates Reverse Stock Split Fair Value Measurements Income Taxes Basic Earnings (Loss) Per Share Advertising Revenue Recognition Research and Development Cost Stock-Based Compensation Segment Reporting Recent Accounting Pronouncements SCHEDULE OF FAIR VALUE HIERARCHY MEASURED AT RECURRING BASIS SCHEDULE OF DERIVATIVE LIABILITY ON CONVERTIBLE NOTES USING BLACK SCHOLES PRICING MODEL SCHEDULE OF ACCOUNTS RECEIVABLE SCHEDULE OF PREPAID EXPENSES SCHEDULE OF ACCRUED EXPENSES SCHEDULE OF NOTES PAYABLE TO NON RELATED PARTY SCHEDULE OF NOTES PAYABLE TO RELATED PARTIES SCHEDULE OF CONVERTIBLE NOTES SCHEDULE OF DERIVATIVE LIABILITY SCHEDULE OF DEFERRED TAX ASSETS Investment Securities (Related Party) Derivative Liability Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Line Items] Expected Dividends Net loss Accumulated deficit Reverse stock split description Reverse stock split Operating loss carry forward valuation allowance percentage Advertising expense Research and development expense Number of reportable segment Total – Accounts receivables Allowance for doubtful accounts Schedule Of Prepaid Expenses Total – Prepaid expenses Accrued payroll taxes Accrued Interest Accrued Payroll Accrued Rent Other Accrued Expenses Total Accrued Expenses DisclosureUnearnedIncomeTable [Table] Nonrefundable fee Ownership percentage Fair value of stock Cash prepaid Short-Term Debt [Table] Short-Term Debt [Line Items] Total notes payable Less – Accumulated amortization Total notes payable DebtDisclosureTable [Table] Due and payable amount Interest rate Total notes payable to related parties Less – current portion Total Long Term notes payable RelatedPartyTransactionsTable [Table] Related Party Transaction [Line Items] Notes payable to related parties Interest rate Total convertible notes payable Less – unamortized debt discount Total convertible notes payable Interest rate, percent Maturity date Convertible promissory note Cash issued for convertible note Interest charge, percent Discount conversion, percent Conversion price per share Principal amount Debt term Unsecured promissory note Periodic payment Default note description Convertible note payable Original issue discount Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Line Items] Derivative liabilities Stock, Class of Stock [Table] Class of Stock [Line Items] Non-cumulative cash dividends Preferred stock, liquidation amount Common shares issued for debt, shares Common Shares issued for principal indebtedness Common Shares issued for interest Common Shares issued for expensest, shares Common Shares for cash consideration, shares Common Shares for cash consideration Related Party Transaction [Table] Related party description Minimum annual royalties Prepaid royalties Payments for rent Base rent Related party amount Debt instrument face amount Net operating tax carry forwards Other Gross deferred tax assets Valuation allowance Net deferred tax assets Deferred tax assets Operating loss carry forwards Deferred tax assets net Subsequent Event [Table] Subsequent Event [Line Items] Rights obligation Debt instrument fee Principal convertible indebtedness Principal of debt issued Accrued interest convertible indebtedness Convertible note payable current. Series AA Preferred Stock [Member] Series M Preferred Stock [Member] Series NC Preferred Stock [Member] Rental expense. Financing fees. Preferred Stock Series NC [Member] Stock issued during period value common shares issued for interest. Stock issued during period shares common shares issued for interest. Stock issued during period value restricted stock award nonemployee. Stock issued during period shares restricted stock award nonemployee. Stock issued during period value stock dividends. Stock issued during period shares stock dividends. Common stock issued for compensation. Increase decrease in common stock issued for expenses. Common shares issued for note payable. Convesion of notes payble to convertible debt. Common shares issued for interest. Reverse Stock Split [Policy Text Block] Measurement Input Expected Volatility [Member] Operating loss carry forward valuation allowance percentage. Prepaid Expenses Disclosure [Text Block] Accrued interest. Accrued payroll. Unearned Income Disclosure [Text Block] Amortization of notes. Zander Therapeutics Inc [Member] Due And Payable On May Three Two Thousand Twenty Five [Member] Trillium Pratners LP [Member] Due and Payable On October 4, 2025 [Member] Due and Payable On June 5, 2025 [Member] Due and Payable On October Fifteen Two Thousand Twenty Five [Member] Due And Payable On October Twenty Three Two Thousand Twenty Five [Member] Lender One [Member] Lender Two [Member] Lender Three [Member] Lender Four [Member] Lender Five [Member] Cash issued for convertible note. May 5, 2017 [Member] March 8, 2016 [Member] April Six Two Thousand Sixteen [Member] December 20, 2017 [Member] October 31, 2016 [Member] September 4, 2024 [Member] Guaranted Interest [Member] Debt instrument default description. October 28, 2024 [Member] Regen Biopharma Inc [Member] DebtInstrument Original Discount. Labrys Fund II LP [Member] Non-cumulative cash dividends. David Koos [Member] Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Interest Expense, Nonoperating Amortization of Debt Discount (Premium) Legal Fees FinancingFees Other Noncash Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Prepaid Expense Accounts Payable and Accrued Liabilities, Current Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Unamortized Discount, Current Deferred Tax Assets, Valuation Allowance